Gary Yeung
InvestorGeneral Partner at YK Bioventures · Chief Business Officer at Erasca
San Francisco Bay Area
Find your path to Gary
548 people in our graph share verified history with Gary — schools, employers, funds. One of them is your warm intro.
John de KoningunlockedGary: together at xilis (2021–2023)
×2Gary: together at xilis
×9Gary: together at Duke Capital Partners
Chief Business Officer at Erasca
Intro paths
→
In turn, Gary can intro founders to Erasca's investors below.
Erasca's investors · 8
Andreessen HorowitzMenlo Park · $500K – $50M checks · since 2020ARCH Venture PartnersChicago · $50K – $250M checks · since 2020City Hill VenturesSan Diego · $100K – $20M checks · since 2020Colt VenturesDallas · $15M checks · since 2020Evolution VC PartnersNew York · since 2020Frazier Life SciencesPalo Alto · since 2020LifeSci Venture PartnersNew York · since 2020SignalFireSan Francisco · $250K – $15M checks · since 2018
Co-founders at Erasca
JE
Jonathan E. Lim, M.D.Chairman, CEO and Co-founder
Experience
- YK BioventuresFounder and CIOcurrent2023 — presentSan Francisco Bay Area
- Moonwalk BiosciencesBoard Membercurrent2026 — present
- Shenandoah Therapeutics Inc.Board Membercurrent2025 — present
- Neurona TherapeuticsInvestorcurrent2025 — present
- Vivere OncotherapiesChairperson of the Boardcurrent2024 — present
- AkodioChairperson of the Boardcurrent2026 — presentSan Francisco Bay Area
- Axent BiosciencesBoard Membercurrent2024 — present
- Protego BioBoard Observercurrent2025 — present
- TRIANA BiomedicinesBoard Observercurrent2025 — present
- Topo TherapeuticsBoard Observercurrent2025 — present
- Various CompaniesBoard member and executive advisorcurrent2018 — presentUnited States
- QB3Startup Mentorcurrent2025 — presentSan Francisco Bay Area
- Berkeley Frontier FundScientific Advisory Board Membercurrent2023 — presentBerkeley, California, United States
- Duke Capital PartnersInvestorcurrent2022 — presentNorth Carolina, United States
- Stanford University School of MedicineAdvisor (SPARK Program)current2022 — presentStanford, California, United States
- Dartmouth CollegeAdvisor (Magnuson Center Magnuson Center for Entrepreneurship)current2024 — presentUnited States
- GGTG Biosciences, Inc.Founder and CEO (company achieved exit in Dec 2023)2022 — 2023United States
- xilisCFO and President2021 — 2023San Francisco Bay Area
- Erasca, Inc.Chief Financial Officer and Chief Operating Officer2019 — 2020California, United States
- Erasca, Inc.Chief Business Officer2018 — 2019
- Guardant HealthVice President, Early Cancer Detection Business2018Redwood City, CA
- Annexon BiosciencesVice President, Business and Development Operations2016 — 2017South San Francisco
- GenentechVarious leadership roles2004 — 2016San Francisco Bay Area
- CerusDirector, Business Development and Finance2002 — 2004
- McKinsey & CompanyStrategy and Business Consultant2000 — 2002
- GE Vernova Hitachi Nuclear EnergyProgram Director, Corporate Initiatives1996 — 1998
- General ElectricEdison Engineering Development Program1995 — 1997
- GenentechIntern1994 — 1995South San Francisco, CA
Skills & more
BiotechnologyPharmaceutical IndustryLifesciencesOncologyBiopharmaceuticalsCross-functional Team LeadershipDrug DevelopmentTechnology TransferClinical DevelopmentClinical TrialsCommercializationMedical Devices
+12 more
Product DevelopmentImmunologyStrategic PlanningBusiness StrategyBusiness DevelopmentStart-upsFDAProcess ImprovementCorporate FinanceDrug DiscoveryLeadershipProduct Launch- Chartered Financial Analyst (CFA) — CFA Institute
- Project Management Professional (PMP) — Project Management Institute
From Gary's professional profile.
Colleagues at YK Bioventures
Frequently asked questions
- Who is Gary Yeung?
- General Partner at YK Bioventures
- Where does Gary Yeung work?
- Gary Yeung is General Partner at YK Bioventures and Chief Business Officer at Erasca.
- Where did Gary Yeung go to school?
- Gary Yeung studied at University of California, Berkeley, College of Chemistry (BS, Chemical Engineering); UCLA Anderson School of Management (MBA, Business Administration).
Same school
Also attended University of California, Berkeley, College of Chemistry4
Also attended UCLA Anderson School of Management422
David Clark GuillermoInvestments at Impact America FundDana MoralyPartner; Chief Financial & Administrative Officer at March Capital PartnersJed LeidheiserPartner at March Capital PartnersShahin FarshchiPartner at Lux CapitalMonica PlazaOperating Partner at CapitalGJennifer SavagePartner at Illuminate Ventures
+ 416 more
Shared employers
Also worked at Shenandoah Therapeutics Inc.1
Also worked at Vivere Oncotherapies5
Melissa KottermanVenture Partner at Berkeley FrontierDavid SchafferProfessor of Bioengineering; Co-founder, 4D Molecular and Axent Biosciences (Faculty Advisor) at UC Berkeley SkydeckGary Yeung, CFAChief Business Officer at ErascaAdam SchiefereckeCo-founder; Head of Research at ViveretxHyuncheol LeeCo-founder; Head of Nonclinical Development at Viveretx
Also worked at QB36
Douglas CrawfordManaging General Partner at Mission BiocapitalRichard YuFounder at Abalone BioRegis KellyProfessor, UCSF QB3 Quantitative Biosciences; Director, QB3 Institute (Faculty Advisor) at UC Berkeley SkydeckDavid SchafferProfessor of Bioengineering; Co-founder, 4D Molecular and Axent Biosciences (Faculty Advisor) at UC Berkeley SkydeckAlina SuFounder at Generation LabGary Yeung, CFAChief Business Officer at Erasca
Also worked at Annexon Biosciences7
LaToya CoffeyRegulatory Advisor at 2Flo VenturesDouglas LoveFounder at AnnexonEmmett CunninghamExecutive Officer, Director at EyconisGary Yeung, CFAChief Business Officer at ErascaWilliam WaddillExecutive Officer at Calithera BiosciencesCharles OhChief Medical Officer at Centrexion Therapeutics
+ 1 more









































